R&D Views & Analysis | pharmaphorum

Views & Analysis

The ‘failure’ of clinical trials in the search for a new effective treatment for a global pandemic

The ‘failure’ of clinical trials in the search for COVID-19 ...

Professor Jean-Pierre Boissel outlines the urgent need for disruptive R&D approaches that can tackle the search for COVID-19 treatments more effectively.

R&D

pharmaphorum_podcast-Episode-25-1200x675

GSK and eosinophil research: the pharmaphorum podcast

GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic Syndrome (HES).

Views & Analysis

NICE talking to you: Trends in early HTA engagement

With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look at the trend in early engagemen

Views & Analysis